Cochrane Abstracts
Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Omega‐3 Fatty Acids Supplementation for Autism Spectrum Disorders (ASD)." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Omega‐3_fatty_acids_supplementation_for_autism_spectrum_disorders__ASD_.
Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Omega‐3_fatty_acids_supplementation_for_autism_spectrum_disorders__ASD_. Accessed March 23, 2025.
Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD). (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Omega‐3_fatty_acids_supplementation_for_autism_spectrum_disorders__ASD_
Omega‐3 Fatty Acids Supplementation for Autism Spectrum Disorders (ASD) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Omega‐3_fatty_acids_supplementation_for_autism_spectrum_disorders__ASD_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD)
ID - 438902
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438902/all/Omega‐3_fatty_acids_supplementation_for_autism_spectrum_disorders__ASD_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
